Table 1: Open in new tab Demographic...

	Before propensity score matching	After propensity score matching
Age (median ± SD)	60.5 ± 9.2	61 ± 8.9	0.446	61 ± 9.1	60.8 ± 9.2	0.931
Female	68 (24.3)	16 (8.2)	< 0.001	29 (21)	10 (7.2)	0.001
Male	212 (75.7)	180 (91.8)		109 (79)	128 (92.8)
Left lung	111 (39.6)	62 (31.6)	0.074	50 (36.2)	44 (31.9)	0.446
Right lung	169 (60.4)	134 (68.4)		88 (63.8)	94 (68.1)
Smoking history	225 (80.4)	174 (88.8)	0.014	111 (80.4)	118 (85.5)	0.262
Comorbidity	169 (60.4)	109 (55.6)	0.301	83 (60.1)	73 (52.9)	0.225
Respiratory functions (mean ± SD)
FEV1 (ml)	2387 ± 614	2351 ± 663	0.587	2382 ± 618	2411 ± 673	0.709
FEV1 (%)	86 ± 18	80 ± 18	0.001	84 ± 17	81 ± 18	0.088
FVC (ml)	3190 ± 775	3198 ± 785	0.693	3209 ± 755	3292 ± 790	0.359
FVC (%)	92 ± 17	87 ± 18	0.001	91 ± 15	88 ± 17	0.092
DLCO	83 ± 19	86 ± 20	0.211	83 ± 14	84 ± 13	0.488
Histopathological analysis
Squamous cell carcinoma	129 (46.1)	158 (80.6)	< 0.001	96 (69.6)	100 (72.5)	0.596
Adenocarcinoma	151 (53.9)	38 (19.4)		42 (30.4)	38 (27.5)
T status
T1	56 (20)	58 (29.6)		30 (21.7)	32 (23.2)
T2	76 (27.1)	76 (38.8)	< 0.001	51 (37)	47 (34.1)	0.964
T3	101 (36.1)	42 (21.4)		38 (27.5)	40 (29)
T4	47 (16.8)	20 (10.2)		19 (13.8)	19 (13.8)
N status
N0	187 (66.8)	100 (51)		82 (59.4)	73 (52.9)
N1	63 (22.5)	78 (39.8)	< 0.001	37 (26.8)	53 (38.4)	0.084
N2	30 (10.7)	18 (9.2)		19 (13.8)	12 (8.7)
Pathological stage
I	72 (25.7)	56 (28.6)		40 (29)	32 (23.2)
II	112 (40)	83 (42.3)	0.168	53 (38.4)	58 (42)	0.129
III	90 (32.1)	57 (29.1)		41 (29.4)	48 (34.8)
IV	6 (2.1)			4 (2.9)
Drainage time (days)	6 ± 7.6	6 ± 9.9	0.201	6 ± 5.5	6 ± 9.6	0.665
Hospital stay (days)	9 ± 10.7	10 ± 11.8	0.017	9 ± 8.2	9.5 ± 12	0.271
Complications	189 (67.5)	132 (67.3)	0.972	96 (69.6)	92 (66.7)	0.605
Death (90 days)	6 (2.1)	9 (4.5)	0.132	3 (2.2)	5 (3.6)	0.723
Survival (5 years)	58%	53%	0.398	55%	49%	0.482

Before propensity score matching

After propensity score matching

Standard lobectomy

Sleeve lobectomy

P-value

Standard lobectomy

Sleeve lobectomy

P-value

n = 280 (%)

n = 196 (%)

n = 138 (%)

Age (median ± SD)

60.5 ± 9.2

61 ± 8.9

0.446

61 ± 9.1

60.8 ± 9.2

0.931

Female

68 (24.3)

16 (8.2)

< 0.001

29 (21)

10 (7.2)

0.001

Male

212 (75.7)

180 (91.8)

109 (79)

128 (92.8)

Left lung

111 (39.6)

62 (31.6)

0.074

50 (36.2)

44 (31.9)

0.446

Right lung

169 (60.4)

134 (68.4)

88 (63.8)

94 (68.1)

Smoking history

225 (80.4)

174 (88.8)

0.014

111 (80.4)

118 (85.5)

0.262

Comorbidity

169 (60.4)

109 (55.6)

0.301

83 (60.1)

73 (52.9)

0.225

Respiratory functions (mean ± SD)

FEV1 (ml)

2387 ± 614

2351 ± 663

0.587

2382 ± 618

2411 ± 673

0.709

FEV1 (%)

86 ± 18

80 ± 18

0.001

84 ± 17

81 ± 18

0.088

FVC (ml)

3190 ± 775

3198 ± 785

0.693

3209 ± 755

3292 ± 790

0.359

FVC (%)

92 ± 17

87 ± 18

0.001

91 ± 15

88 ± 17

0.092

DLCO

83 ± 19

86 ± 20

0.211

83 ± 14

84 ± 13

0.488

Histopathological analysis

Squamous cell carcinoma

129 (46.1)

158 (80.6)

< 0.001

96 (69.6)

100 (72.5)

0.596

Adenocarcinoma

151 (53.9)

38 (19.4)

42 (30.4)

38 (27.5)

T status

56 (20)

58 (29.6)

30 (21.7)

32 (23.2)

76 (27.1)

76 (38.8)

< 0.001

51 (37)

47 (34.1)

0.964

101 (36.1)

42 (21.4)

38 (27.5)

40 (29)

47 (16.8)

20 (10.2)

19 (13.8)

N status

187 (66.8)

100 (51)

82 (59.4)

73 (52.9)

63 (22.5)

78 (39.8)

< 0.001

37 (26.8)

53 (38.4)

0.084

30 (10.7)

18 (9.2)

19 (13.8)

12 (8.7)

Pathological stage

72 (25.7)

56 (28.6)

40 (29)

32 (23.2)

112 (40)

83 (42.3)

0.168

53 (38.4)

58 (42)

0.129

III

90 (32.1)

57 (29.1)

41 (29.4)

48 (34.8)

6 (2.1)

4 (2.9)

Drainage time (days)

6 ± 7.6

6 ± 9.9

0.201

6 ± 5.5

6 ± 9.6

0.665

Hospital stay (days)

9 ± 10.7

10 ± 11.8

0.017

9 ± 8.2

9.5 ± 12

0.271

Complications

189 (67.5)

132 (67.3)

0.972

96 (69.6)

92 (66.7)

0.605

Death (90 days)

6 (2.1)

9 (4.5)

0.132

3 (2.2)

5 (3.6)

0.723

Survival (5 years)

58%

53%

0.398

55%

49%

0.482

	Before propensity score matching	After propensity score matching
Age (median ± SD)	60.5 ± 9.2	61 ± 8.9	0.446	61 ± 9.1	60.8 ± 9.2	0.931
Female	68 (24.3)	16 (8.2)	< 0.001	29 (21)	10 (7.2)	0.001
Male	212 (75.7)	180 (91.8)		109 (79)	128 (92.8)
Left lung	111 (39.6)	62 (31.6)	0.074	50 (36.2)	44 (31.9)	0.446
Right lung	169 (60.4)	134 (68.4)		88 (63.8)	94 (68.1)
Smoking history	225 (80.4)	174 (88.8)	0.014	111 (80.4)	118 (85.5)	0.262
Comorbidity	169 (60.4)	109 (55.6)	0.301	83 (60.1)	73 (52.9)	0.225
Respiratory functions (mean ± SD)
FEV1 (ml)	2387 ± 614	2351 ± 663	0.587	2382 ± 618	2411 ± 673	0.709
FEV1 (%)	86 ± 18	80 ± 18	0.001	84 ± 17	81 ± 18	0.088
FVC (ml)	3190 ± 775	3198 ± 785	0.693	3209 ± 755	3292 ± 790	0.359
FVC (%)	92 ± 17	87 ± 18	0.001	91 ± 15	88 ± 17	0.092
DLCO	83 ± 19	86 ± 20	0.211	83 ± 14	84 ± 13	0.488
Histopathological analysis
Squamous cell carcinoma	129 (46.1)	158 (80.6)	< 0.001	96 (69.6)	100 (72.5)	0.596
Adenocarcinoma	151 (53.9)	38 (19.4)		42 (30.4)	38 (27.5)
T status
T1	56 (20)	58 (29.6)		30 (21.7)	32 (23.2)
T2	76 (27.1)	76 (38.8)	< 0.001	51 (37)	47 (34.1)	0.964
T3	101 (36.1)	42 (21.4)		38 (27.5)	40 (29)
T4	47 (16.8)	20 (10.2)		19 (13.8)	19 (13.8)
N status
N0	187 (66.8)	100 (51)		82 (59.4)	73 (52.9)
N1	63 (22.5)	78 (39.8)	< 0.001	37 (26.8)	53 (38.4)	0.084
N2	30 (10.7)	18 (9.2)		19 (13.8)	12 (8.7)
Pathological stage
I	72 (25.7)	56 (28.6)		40 (29)	32 (23.2)
II	112 (40)	83 (42.3)	0.168	53 (38.4)	58 (42)	0.129
III	90 (32.1)	57 (29.1)		41 (29.4)	48 (34.8)
IV	6 (2.1)			4 (2.9)
Drainage time (days)	6 ± 7.6	6 ± 9.9	0.201	6 ± 5.5	6 ± 9.6	0.665
Hospital stay (days)	9 ± 10.7	10 ± 11.8	0.017	9 ± 8.2	9.5 ± 12	0.271
Complications	189 (67.5)	132 (67.3)	0.972	96 (69.6)	92 (66.7)	0.605
Death (90 days)	6 (2.1)	9 (4.5)	0.132	3 (2.2)	5 (3.6)	0.723
Survival (5 years)	58%	53%	0.398	55%	49%	0.482

Table 1:

Open in new tab

Demographic features of the standard lobectomy versus the sleeve lobectomy groups before and after propensity score matching

	Before propensity score matching			After propensity score matching
	Standard lobectomy	Sleeve lobectomy	P-value	Standard lobectomy	Sleeve lobectomy	P-value
	n = 280 (%)	n = 196 (%)		Standard lobectomy	Sleeve lobectomy
	n = 280 (%)	n = 196 (%)		n = 138 (%)	n = 138 (%)
Age (median ± SD)	60.5 ± 9.2	61 ± 8.9	0.446	61 ± 9.1	60.8 ± 9.2	0.931
Female	68 (24.3)	16 (8.2)	< 0.001	29 (21)	10 (7.2)	0.001
Male	212 (75.7)	180 (91.8)		109 (79)	128 (92.8)
Left lung	111 (39.6)	62 (31.6)	0.074	50 (36.2)	44 (31.9)	0.446
Right lung	169 (60.4)	134 (68.4)		88 (63.8)	94 (68.1)
Smoking history	225 (80.4)	174 (88.8)	0.014	111 (80.4)	118 (85.5)	0.262
Comorbidity	169 (60.4)	109 (55.6)	0.301	83 (60.1)	73 (52.9)	0.225
Respiratory functions (mean ± SD)
FEV1 (ml)	2387 ± 614	2351 ± 663	0.587	2382 ± 618	2411 ± 673	0.709
FEV1 (%)	86 ± 18	80 ± 18	0.001	84 ± 17	81 ± 18	0.088
FVC (ml)	3190 ± 775	3198 ± 785	0.693	3209 ± 755	3292 ± 790	0.359
FVC (%)	92 ± 17	87 ± 18	0.001	91 ± 15	88 ± 17	0.092
DLCO	83 ± 19	86 ± 20	0.211	83 ± 14	84 ± 13	0.488
Histopathological analysis
Squamous cell carcinoma	129 (46.1)	158 (80.6)	< 0.001	96 (69.6)	100 (72.5)	0.596
Adenocarcinoma	151 (53.9)	38 (19.4)		42 (30.4)	38 (27.5)
T status
T1	56 (20)	58 (29.6)		30 (21.7)	32 (23.2)
T2	76 (27.1)	76 (38.8)	< 0.001	51 (37)	47 (34.1)	0.964
T3	101 (36.1)	42 (21.4)		38 (27.5)	40 (29)
T4	47 (16.8)	20 (10.2)		19 (13.8)	19 (13.8)
N status
N0	187 (66.8)	100 (51)		82 (59.4)	73 (52.9)
N1	63 (22.5)	78 (39.8)	< 0.001	37 (26.8)	53 (38.4)	0.084
N2	30 (10.7)	18 (9.2)		19 (13.8)	12 (8.7)
Pathological stage
I	72 (25.7)	56 (28.6)		40 (29)	32 (23.2)
II	112 (40)	83 (42.3)	0.168	53 (38.4)	58 (42)	0.129
III	90 (32.1)	57 (29.1)		41 (29.4)	48 (34.8)
IV	6 (2.1)			4 (2.9)
Drainage time (days)	6 ± 7.6	6 ± 9.9	0.201	6 ± 5.5	6 ± 9.6	0.665
Hospital stay (days)	9 ± 10.7	10 ± 11.8	0.017	9 ± 8.2	9.5 ± 12	0.271
Complications	189 (67.5)	132 (67.3)	0.972	96 (69.6)	92 (66.7)	0.605
Death (90 days)	6 (2.1)	9 (4.5)	0.132	3 (2.2)	5 (3.6)	0.723
Survival (5 years)	58%	53%	0.398	55%	49%	0.482

	Before propensity score matching			After propensity score matching
	Standard lobectomy	Sleeve lobectomy	P-value	Standard lobectomy	Sleeve lobectomy	P-value
	n = 280 (%)	n = 196 (%)		Standard lobectomy	Sleeve lobectomy
	n = 280 (%)	n = 196 (%)		n = 138 (%)	n = 138 (%)
Age (median ± SD)	60.5 ± 9.2	61 ± 8.9	0.446	61 ± 9.1	60.8 ± 9.2	0.931
Female	68 (24.3)	16 (8.2)	< 0.001	29 (21)	10 (7.2)	0.001
Male	212 (75.7)	180 (91.8)		109 (79)	128 (92.8)
Left lung	111 (39.6)	62 (31.6)	0.074	50 (36.2)	44 (31.9)	0.446
Right lung	169 (60.4)	134 (68.4)		88 (63.8)	94 (68.1)
Smoking history	225 (80.4)	174 (88.8)	0.014	111 (80.4)	118 (85.5)	0.262
Comorbidity	169 (60.4)	109 (55.6)	0.301	83 (60.1)	73 (52.9)	0.225
Respiratory functions (mean ± SD)
FEV1 (ml)	2387 ± 614	2351 ± 663	0.587	2382 ± 618	2411 ± 673	0.709
FEV1 (%)	86 ± 18	80 ± 18	0.001	84 ± 17	81 ± 18	0.088
FVC (ml)	3190 ± 775	3198 ± 785	0.693	3209 ± 755	3292 ± 790	0.359
FVC (%)	92 ± 17	87 ± 18	0.001	91 ± 15	88 ± 17	0.092
DLCO	83 ± 19	86 ± 20	0.211	83 ± 14	84 ± 13	0.488
Histopathological analysis
Squamous cell carcinoma	129 (46.1)	158 (80.6)	< 0.001	96 (69.6)	100 (72.5)	0.596
Adenocarcinoma	151 (53.9)	38 (19.4)		42 (30.4)	38 (27.5)
T status
T1	56 (20)	58 (29.6)		30 (21.7)	32 (23.2)
T2	76 (27.1)	76 (38.8)	< 0.001	51 (37)	47 (34.1)	0.964
T3	101 (36.1)	42 (21.4)		38 (27.5)	40 (29)
T4	47 (16.8)	20 (10.2)		19 (13.8)	19 (13.8)
N status
N0	187 (66.8)	100 (51)		82 (59.4)	73 (52.9)
N1	63 (22.5)	78 (39.8)	< 0.001	37 (26.8)	53 (38.4)	0.084
N2	30 (10.7)	18 (9.2)		19 (13.8)	12 (8.7)
Pathological stage
I	72 (25.7)	56 (28.6)		40 (29)	32 (23.2)
II	112 (40)	83 (42.3)	0.168	53 (38.4)	58 (42)	0.129
III	90 (32.1)	57 (29.1)		41 (29.4)	48 (34.8)
IV	6 (2.1)			4 (2.9)
Drainage time (days)	6 ± 7.6	6 ± 9.9	0.201	6 ± 5.5	6 ± 9.6	0.665
Hospital stay (days)	9 ± 10.7	10 ± 11.8	0.017	9 ± 8.2	9.5 ± 12	0.271
Complications	189 (67.5)	132 (67.3)	0.972	96 (69.6)	92 (66.7)	0.605
Death (90 days)	6 (2.1)	9 (4.5)	0.132	3 (2.2)	5 (3.6)	0.723
Survival (5 years)	58%	53%	0.398	55%	49%	0.482

DLCO: diffusion capacity for carbon monoxide; FEV1: forced expiratory volume in first second; FVC: forced vital capacity; N: node; SD: standard deviation; T: tumour.

P < 0.05 values were bolded.

This Feature Is Available To Subscribers Only